Phase
Condition
Polymyositis (Inflammatory Muscle Disease)
Sarcopenia
Inflammation
Treatment
NaCl 0.9%
Methylprednisolone
Clinical Study ID
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged 60 years or older.
Scheduled for one of the predefined surgical procedures:
off-pump coronary bypass surgery
on-pump coronary bypass surgery
aortic and mitral valve replacement
laparoscopic hemicolectomies
thoracoscopic lung resections
femoral popliteal and tibial bypass surgery and femoral profundoplasty
laparoscopic radical prostatectomies
Exclusion
Exclusion Criteria:
Lack of informed consent or inability to give informed consent.
Severe postoperative nausea & vomiting (PONV), needing corticosteroids as PONVprophylaxis.
Urgent, not elective surgery
Hypersensitivity or known allergic reactions to methylprednisolone
Preoperative systemic use of steroids:
Including, but not limited to, the use of corticosteroids > 4 weeks beforesurgery of at least 4 mg methylprednisolone equivalents.
Excluding inhalational and topical steroids
Preexisting muscle disease o Including, but not limited to: Steinert's disease,amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant armor hand.
Study Design
Study Description
Connect with a study center
Ziekenhuis Oost-Limburg
Genk,
BelgiumSite Not Available
Ziekenhuis Oost-Limburg
Genk 2797670,
BelgiumSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.